title: Arachidonate 15-lipoxygenase is required for chronic myeloid leukemia stem cell survival.
abstract: Cancer stem cells (CSCs) are responsible for the initiation and maintenance of some types of cancer, suggesting that inhibition of these cells may limit disease progression and relapse. Unfortunately, few CSC-specific genes have been identified. Here, we determined that the gene encoding arachidonate 15-lipoxygenase (Alox15/15-LO) is essential for the survival of leukemia stem cells (LSCs) in a murine model of BCR-ABL-induced chronic myeloid leukemia (CML). In the absence of Alox15, BCR-ABL was unable to induce CML in mice. Furthermore, Alox15 deletion impaired LSC function by affecting cell division and apoptosis, leading to an eventual depletion of LSCs. Moreover, chemical inhibition of 15-LO function impaired LSC function and attenuated CML in mice. The defective CML phenotype in Alox15-deficient animals was rescued by depleting the gene encoding P-selectin, which is upregulated in Alox15-deficient animals. Both deletion and overexpression of P-selectin affected the survival of LSCs. In human CML cell lines and CD34+ cells, knockdown of Alox15 or inhibition of 15-LO dramatically reduced survival. Loss of Alox15 altered expression of PTEN, PI3K/AKT, and the transcription factor ICSBP, which are known mediators of cancer pathogenesis. These results suggest that ALOX15 has potential as a therapeutic target for eradicating LSCs in CML.
authors.forename: Yaoyu
authors.initials: Y
authors.lastname: Chen
authors.forename: Cong
authors.initials: C
authors.lastname: Peng
authors.forename: Sheela A
authors.initials: SA
authors.lastname: Abraham
authors.forename: Yi
authors.initials: Y
authors.lastname: Shan
authors.forename: Zhiru
authors.initials: Z
authors.lastname: Guo
authors.forename: Ngoc
authors.initials: N
authors.lastname: Desouza
authors.forename: Giulia
authors.initials: G
authors.lastname: Cheloni
authors.forename: Dongguang
authors.initials: D
authors.lastname: Li
authors.forename: Tessa L
authors.initials: TL
authors.lastname: Holyoake
authors.forename: Shaoguang
authors.initials: S
authors.lastname: Li
mesh_terms: D000818:Animals; D017209:Apoptosis; D001093:Arachidonate 15-Lipoxygenase / Q000235:genetics / Q000502:physiology*; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D005449:Fluorenes / Q000494:pharmacology; D016044:Fusion Proteins, bcr-abl / Q000502:physiology; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000209:etiology / Q000473:pathology*; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D014411:Neoplastic Stem Cells / Q000502:physiology*; D019007:P-Selectin / Q000502:physiology
chemical_list: C106248:6,11-dihydro-5-thia-11-aza-benzo(a)-fluorene; D005449:Fluorenes; D016859:Lipoxygenase Inhibitors; D019007:P-Selectin; D001093:Arachidonate 15-Lipoxygenase; D016044:Fusion Proteins, bcr-abl
references.citation: N Engl J Med. 2006 Sep 21;355(12):1253-61
references.pmid: 16990388
references.citation: Nature. 2001 May 17;411(6835):349-54
references.pmid: 11357142
references.citation: Cancer Res. 2003 Sep 15;63(18):5821-8
references.pmid: 14522905
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2794-9
references.pmid: 16477019
references.citation: Nature. 2003 May 15;423(6937):302-5
references.pmid: 12714971
references.citation: Biochem Pharmacol. 2007 Jul 15;74(2):202-14
references.pmid: 17517376
references.citation: Nature. 2006 May 25;441(7092):475-82
references.pmid: 16598206
references.citation: Nat Genet. 2012 Jul 15;44(8):861-71
references.pmid: 22797726
references.citation: Nature. 2010 Feb 4;463(7281):676-80
references.pmid: 20130650
references.citation: PLoS One. 2011;6(10):e26246
references.pmid: 22039451
references.citation: Cancer Cell. 2008 Sep 9;14(3):238-49
references.pmid: 18772113
references.citation: Cell. 2008 Feb 22;132(4):681-96
references.pmid: 18295583
references.citation: Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16870-5
references.pmid: 17077147
references.citation: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
references.pmid: 12629218
references.citation: Nature. 2010 Aug 5;466(7307):765-8
references.pmid: 20639863
references.citation: Nat Med. 1997 Jul;3(7):730-7
references.pmid: 9212098
references.citation: Blood. 2009 Nov 5;114(19):4186-96
references.pmid: 19738029
references.citation: Nature. 2003 May 15;423(6937):255-60
references.pmid: 12714970
references.citation: Cell Stem Cell. 2013 Mar 7;12(3):316-28
references.pmid: 23333150
references.citation: Trends Cell Biol. 2005 Sep;15(9):494-501
references.pmid: 16084092
references.citation: Science. 2004 Jan 9;303(5655):229-32
references.pmid: 14716014
references.citation: Nat Rev Mol Cell Biol. 2008 Feb;9(2):162-76
references.pmid: 18216772
references.citation: Nature. 2003 May 22;423(6938):409-14
references.pmid: 12717450
references.citation: Nature. 2009 Apr 9;458(7239):776-9
references.pmid: 19169242
references.citation: Exp Hematol. 2000 May;28(5):551-7
references.pmid: 10812245
references.citation: Blood. 2010 Jan 21;115(3):626-35
references.pmid: 19965668
references.citation: Nat Genet. 2009 Jul;41(7):783-92
references.pmid: 19503090
references.citation: Blood. 2007 Jul 15;110(2):678-85
references.pmid: 17395781
references.citation: J Exp Med. 1999 May 3;189(9):1399-412
references.pmid: 10224280
references.citation: Blood. 2010 Jun 17;115(24):5012-22
references.pmid: 20357242
references.citation: EMBO J. 2001 Dec 3;20(23):6793-804
references.pmid: 11726515
references.citation: PLoS One. 2012;7(6):e38614
references.pmid: 22675576
references.citation: Nature. 1994 Feb 17;367(6464):645-8
references.pmid: 7509044
references.citation: Cancer Cell. 2007 Dec;12(6):528-41
references.pmid: 18068630
references.citation: Cancer Cell. 2005 Nov;8(5):355-68
references.pmid: 16286244
references.citation: Nature. 2001 Nov 1;414(6859):105-11
references.pmid: 11689955
references.citation: Nature. 2008 Jun 19;453(7198):1072-8
references.pmid: 18469801
references.citation: Nat Rev Cancer. 2003 Dec;3(12):895-902
references.pmid: 14737120
references.citation: Genes Dev. 2005 Jun 15;19(12):1432-7
references.pmid: 15964994
references.citation: Blood. 2002 Jan 1;99(1):319-25
references.pmid: 11756187
references.citation: Leukemia. 2009 Jan;23(1):109-16
references.pmid: 18818703
references.citation: Prog Lipid Res. 2006 Jul;45(4):334-56
references.pmid: 16678271
references.citation: Nat Genet. 2004 May;36(5):453-61
references.pmid: 15098032
references.citation: J Exp Med. 2006 Oct 30;203(11):2529-40
references.pmid: 17043146
references.citation: Curr Opin Cell Biol. 2004 Dec;16(6):700-7
references.pmid: 15530784
references.citation: Blood. 2004 Oct 1;104(7):2163-71
references.pmid: 15213099
references.citation: Curr Opin Genet Dev. 2003 Feb;13(1):77-83
references.pmid: 12573439
references.citation: Cancer Res. 2013 Sep 15;73(18):5775-86
references.pmid: 23887971